Bioverativ to Report Third Quarter 2017 Financial Results on October 26, 2017
September 28 2017 - 10:30AM
Business Wire
Bioverativ Inc. (NASDAQ: BIVV) will report its financial results
for the third quarter ending September 30, 2017, on Thursday,
October 26, 2017, after the market closes. The press release will
be available in the “Investor Relations” section of the company’s
website at investors.bioverativ.com.
On Friday, October 27, 2017, at 8:00 a.m. EDT, the company will
host a live webcast where Bioverativ management will discuss the
financial results. To access the live webcast, please visit
Bioverativ’s Investors page at investors.bioverativ.com. An
archived version of the webcast will be available following the
presentation.
About Bioverativ
Bioverativ (NASDAQ: BIVV) is a global biopharmaceutical company
dedicated to transforming the lives of people with hemophilia and
other rare blood disorders through world-class research,
development and commercialization of innovative therapies. Launched
in 2017 following separation from Biogen Inc., Bioverativ builds
upon a strong heritage of scientific innovation and is committed to
actively working with the blood disorders community. The company’s
mission is to create progress for patients where they need it most
and its hemophilia therapies when launched represented the first
major advancements in hemophilia treatment in more than two
decades. For more information, visit www.bioverativ.com or follow
@bioverativ on Twitter.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170928005808/en/
INVESTOR CONTACT:Bioverativ Inc.Susan Altschuller, Ph.D.,
+1 781-663-4360IR@bioverativ.com
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bioverativ Inc. (NASDAQ:BIVV)
Historical Stock Chart
From Apr 2023 to Apr 2024